8-K
Current Report
Spyre Therapeutics, Inc. Filed Acc 0001564590-21-059372
Regulation FD disclosure · Other events
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading agle-8k_20211206.htm…